GMP Inspection report post 24 August 2023
Dear Medicines and Healthcare Products Regulatory Agency,
Please provide GMP inspection report of parenterals product manufacturing sites conducted after 23 august 2023 in the UK
Yours faithfully,
S. Milosevic
Thank you for your email. This auto-response is to inform you that your
email has been received and will be reviewed by our Customer Experience
Centre Team. We will respond to you as soon as possible.
Please note that we may not respond if your query:
· contains offensive language
· has already been answered in a previous reply to you
· is illegible
· is selling or promoting a product
· is for information only
Kind regards
MHRA Customer Experience Centre
Medicines and Healthcare products Regulatory Agency
10 South Colonnade, Canary Wharf, London E14 4PU
DISCLAIMER This email and any files transmitted with it are confidential.
If you are not the intended recipient, any reading, printing, storage,
disclosure, copying or any other action taken in respect of this email is
prohibited and may be unlawful. If you are not the intended recipient,
please notify the sender immediately by using the reply function and then
permanently delete what you have received. Incoming and outgoing email
messages are routinely monitored for compliance with the Department of
Health's policy on the use of electronic communications. For more
information on the Department of Health's email policy, click
[1]DHTermsAndConditions
References
Visible links
1. https://www.gov.uk/help/terms-conditions
MHRA reference: FOI2024/00013
Dear S. Milosevic,
Thank you for your information request, which we received on 26 March. We
have understood your request to be for the following information:
Dear Medicines and Healthcare Products Regulatory Agency, Please provide
GMP inspection report of parenterals product manufacturing sites conducted
after 23 august 2023 in the UK
If we have misunderstood or misinterpreted your request, please contact us
as soon as possible.
We will deal with your request under the Freedom of Information Act 2000
(FOIA). The statutory time frame for response is 20 working days; this
begins on the first working day after receipt, and we will respond by 25
April 2024.
If you need to contact us about this request, please quote the reference
number above.
We publish our responses to FOI requests with requester details removed.
You can view these on our website here:
[1]Transparency and freedom of information releases - GOV.UK (www.gov.uk)
Yours sincerely
Healthcare, Quality and Access Group
Medicines and Healthcare products Regulatory Agency
10 South Colonnade, Canary Wharf, London E14 4PU
Telephone 020 3080 6000
[2]gov.uk/mhra
[3]Stay connected
For information on how the Agency uses your personal data and your data
protection rights, please see our three centres' Privacy Notices: [4]MHRA,
[5]CPRD and [6]NIBSC.
References
Visible links
1. https://eur01.safelinks.protection.outlo...
2. https://eur01.safelinks.protection.outlo...
3. https://eur01.safelinks.protection.outlo...
4. https://eur01.safelinks.protection.outlo...
5. https://eur01.safelinks.protection.outlo...
6. https://eur01.safelinks.protection.outlo...
Dear S. Milosevic,
I am writing in response to your request for information, received 26th
March.
Yours sincerely,
FOI Team
We work to defend the right to FOI for everyone
Help us protect your right to hold public authorities to account. Donate and support our work.
Donate Now